MedMarket Diligence, LLC

Traditional wound management is comprised of technologies that do little to accelerate wound healing. Given chronic wound costs, advanced technologies are now being rapidly adopted to change this, according to a new MedMarket Diligence report.

While the huge $5 billion global market for wound management technologies may not suggest it, many of its products are designed to target the high cost of wound healing. Chronic wounds and non-healing wounds. See the 2009 MedMarket Diligence report.

The coronary stents market is dominated by drug-eluting stents, but the market for anti-restenosis has proven dynamic due to many active companies with diverse technologies targeting this area of cardiovascular treatment.

The global coronary stent market faces continued growth, development and competition from a wide range of technology types and competitors. The market is detailed in a new report from MedMarket Diligence.

Coronary artery disease treatments have faced a succession of new technology solutions that have led to the large, but now competitive drug-eluting stents market, but the success of developments continues with more challenges and opportunities.

Medical and surgical patient caseload continues to grow for the use of the broad category of products called "surgical securement", according to a 2009 report by MedMarket Diligence, LLC.

Treatment of coronary artery disease has become a hotbed for evaluation of an incredible range of alternatives, but drug-eluting stents (DES) clearly represent the most attractive option, according to a new report from MedMarket Diligence (MMD).

The market for coronary stents worldwide is well established, large and still demonstrating excellent growth, especially with the advent of new technologies from established and hopeful competitors, according to a new report from MedMarket Diligence.

Coronary artery disease is addressed by a range alternative treatment methodologies; percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other options, but stents represent the fastest growing option.

The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of divese energy types to tissue.